NCT04779840

Retrospective Study on the Incidence and Management of Anemia in Oncology

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 349 (actual)
• Sponsor: Weprom · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The incidence of anemia ranges from 20 to 75% depending on the type of cancer. It is often present at diagnosis and increases with specific treatments. It has an impact on overall survival and quality of life. Its origins are multiple (pure iron deficiency or functional, malnutrition, dyserythropoiesis, insufficiency renal, hemolysis, chemotherapy, radiotherapy, targeted therapies). Transfusion is the most common treatment offered in the management of anemia. The incidence of anemia and its consequences are often underestimated during cancer management. Recommendations were published in 2012. An inventory of the incidence of anemia before and after the publication of these recommendations are proposed in order to assess their impact on daily practice.

Conditions

• Anemia
• Cancer

Interventions

Type	Name	Description
OTHER	anemia assessment	evaluation of anemia status

Timeline

• Start date: 2020-05-20
• Primary completion: 2021-01-20
• Completion: 2021-01-20
• First posted: 2021-03-03
• Last updated: 2021-03-03

Locations

1 site across 1 country: France